)
Jeppe Øvlesen
Chief Executive Officer
Synact Pharma
Mr. Øvlesen is an experienced biotech executive and has been involved as founder/CEO/Chairman/board member in a string of successful companies including Action Pharma, CLC Bio, Cetrea, ChemoMetec, Perfusion Tech, Resother Pharma, Cercare Medical, PNN Medical, GO Pen, Cereno Scientific and TXP Pharma. Mr. Øvlesen was CEO of Synact Pharma from 2015-2023 taking the company public at Spotlight and later at Nasdaq (Stockholm). Mr. Øvlesen returned as CEO and Board Member in SynAct Pharma in 2024. Mr. Øvlesen holds an MBA from University of Hartford, United States.
Sessions
-
24-Jun-2026Theater 3Synact Pharma
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}